Alertas Bibliográficas
DIABETES
Comparative Cardiovascular Effectiveness and Safety of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to Frailty in Type 2 Diabetes
Kutz A, Kim D,Wexler D, Liu J, Schneeweiss S, Glynn R and Patorno E
Diabetes Care 2023;46(11):2004–2014
https://doi.org/10.2337/dc23-0671
The challenges of identifying and studying type 1 diabetes in adults
ThomasJ, Jones ADiabetologia: December;2023;66: 2200 – 2212
https://doi.org/10.1007/s00125-023-06004-4
ENDOCRINOLOGÍA
Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition: an ESE clinical practice guideline
Eystein S Husebye, Frederik Castinetti, et al.
Eur J Endocrinol. 2022 Oct 25;187(6):G1-G21.
https://doi.org/10.1530/EJE-22-0689
Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement
Margaret C S Boguszewski, Cesar L Boguszewski , et al.
Eur J Endocrinol. 2022 Apr 21;186(6):P35-P52.
https://doi.org/10.1530/EJE-21-1186
Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop
John P Bilezikian 1, Aliya A Khan, et al.
J Bone Miner Res. 2022 Nov;37(11):2293-2314.
https://doi.org/10.1002/jbmr.4677
Genetics of Cushing’s disease: from the lab to clinical practice
Marily Theodoropoulou , Martin Reincke
Pituitary. 2022 Oct;25(5):689-692.
https://doi.org/10.1007/s11102-022-01253-9
Tumor-induced Osteomalacia: A Comprehensive Review
Salvatore Minisola , Seiji Fukumoto, et al.
Endocr Rev. 2023 Mar 4;44(2):323-353.
https://doi.org/10.1210/endrev/bnac026
Update on Biology and Genomics of Adrenocortical Carcinomas: Rationale for Emerging Therapies
Antonio Marcondes Lerario, Dipika R Mohan, Gary D Hammer, et al.
Endocr Rev. 2022 Nov 25;43(6):1051-1073.
https://doi.org/10.1210/endrev/bnac012
Management of thyroid eye disease: a Consensus Statement by the American Thyroid Association and the European Thyroid Association.
Burch, H. B., Perros, P., et al.
Eur Thyroid J. 2022 Dec 1; 11(6): e220189.
https://doi.org/10.1530/ETJ-22-0189
Standards of Care for the Health of Transgender and Gender Diverse People, Version 8.
Coleman, E., Radix, A. E. et al.
International journal of transgender health, 23(Suppl 1), S1–S259.
https://doi.org/10.1080/26895269.2022.2100644
Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline
Ghada El-Hajj Fuleihan, Gregory A Clines, et al.
J Clin Endocrinol Metab. 2023 Feb 15;108(3):507-528. doi: 10.1210/clinem/dgac621.
DOI: 10.1210/clinem/dgac621
Diagnosis and Management of Central Diabetes Insipidus in Adults
Maria Tomkins, Sarah Lawless, et al.
J Clin Endocrinol Metab. 2022 Sep 28;107(10):2701-2715.
doi: 10.1210/clinem/dgac381
PEDIATRÍA
Liraglutide in Children and Adolescents with Type 2 Diabetes.
Tamborlane WV, Barrientos-Pérez M, Fainberg U, Frimer-Larsen H, Hafez M, Hale PM, et al.
N Engl J Med. 2019 Aug 15;381(7):637-646.
http://doi.org/10.1056/NEJMoa1903822
Could AGE/RAGE-Related Oxidative Homeostasis Dysregulation Enhance Susceptibility to Pathogenesis of Cardio-Metabolic Complications in Childhood Obesity?
Corica D, Aversa T, Ruggeri RM, Cristani M, Alibrandi A, et al.
Front Endocrinol (Lausanne). 2019 Jun 28;10:426.
http://doi.org/10.3389/fendo.2019.00426
CIENCIAS BÁSICAS
Mechanisms of Insulin Action and Insulin Resistance.
Petersen MC, Shulman GI.
Physiol Rev. 2018 Oct 1;98(4):2133-2223.
http://doi.org/10.1152/physrev.00063.2017
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).
Buzzetti E, Pinzani M, Tsochatzis EA.
Metabolism. 2016 Aug;65(8):1038-48.
http://doi.org/10.1016/j.metabol.2015.12.012